Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
Hello, you are using an old browser that's unsafe and no longer supported. Please consider updating your browser to a newer version, or downloading a modern browser.
 The Open House, which will be centered around our psychosis research and treatment programs, will consist of lectures, information sharing, and a panel discussion. This event is open to all […]
Presented by SAMHSA and New England Mental Health Technology Transfer Center Network (MHTTC). The Early First Episode Program at the University of New Mexico's Department of Psychiatry and Behavioral Sciences […]
Per Stanford, in this workshop attendees will gain an understanding of an evidence-based cognitive model for those at Clinical High Risk for psychosis (CHRp) with real world examples of the […]
An EPICENTER Speakers Series. RECORDING HERE.
Per the Brain and Behavior Research Foundation, among individuals with psychotic disorders, cognitive impairment is among the strongest determinants of the ability to function in the community. Dr. McCleery will […]
A HeadsUp in house training for PA and MD FEP programs, and collaborating Philadelphia and Coatsville VA Programs. For more information email: headsuppaorg@gmail.com
From the National Council for Mental Wellbeing: Health equity and racial justice experts reflect on the connections between advancing equity, first as an individual, then as an organization and, finally, […]
In house training for PA and MD FEP programs, and collaborating Philadelphia and Coatsville VA Programs. For more information email: headssuppaorg@gmail.com
Given the continued emergence of an interconnected society, a global pandemic, and recent protests and unrest calling for racial justice across the country, building organizational capacity for advancing equity, diversity, […]
From SMI Advisor: Get an in-depth review of the pharmacodynamic and pharmacokinetic properties of clozapine and its use in treatment-resistant schizophrenia. REGISTER HERE.
Catherine (Cat) Conroy, M.Ed, Manager of HeadsUp
Neurodevelopment and Psychosis Section, Department of Psychiatry
Perelman School of Medicine, University of Pennsylvania
10th floor, Gates Pavilion, HUP
3400 Spruce Street, Rm. 10054, Philadelphia, PA 19104
headsuppaorg@gmail.com
We are available during standard business hours (Monday-Friday, 9am-5pm) to answer any questions you may have about our organization or to direct you to programs in Pennsylvania that can offer clinical help.
